• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

删除肿瘤坏死因子样弱凋亡诱导因子(TWEAK)可保护小鼠免受严重肥胖的脂肪和全身影响。

Deletion of TNF-like weak inducer of apoptosis (TWEAK) protects mice from adipose and systemic impacts of severe obesity.

机构信息

Obesity and Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA.

出版信息

Obesity (Silver Spring). 2014 Jun;22(6):1485-94. doi: 10.1002/oby.20726. Epub 2014 Mar 8.

DOI:10.1002/oby.20726
PMID:24616441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4283503/
Abstract

OBJECTIVE

To investigate the role of TNF-like weak inducer of apoptosis (TWEAK) in pathological adipose tissue (AT) remodeling and complications of obesity.

METHODS

Wild type (WT) and TWEAK knockout (KO) mice were fed normal diet (ND) or a high fat diet (HFD) for up to 17 weeks. Adipocyte death was induced using an established transgenic mouse model of inducible adipocyte apoptosis (FAT-ATTAC). Metabolic, biochemical, histologic, and flow cytometric analyses were performed.

RESULTS

TWEAK and its receptor, fibroblast growth factor-inducible molecule 14 (Fn14) were upregulated in gonadal (g)AT of WT mice after HFD week 4 and 24 h after induction of adipocyte apoptosis. Phenotypes of KO and WT mouse were indistinguishable through HFD week 8. However, at week 17 obese KO mice had ∼30% larger gAT adipocytes and gAT mass than WT mice, coincident with reduced adipocyte death, enhanced insulin signaling, Th2/M2 immune skewing, fewer thick collagen fibers, and altered expression of extracellular matrix constituents and modulators that is consistent with reduced fibrosis and larger adipocytes. KO mice were less steatotic and became more insulin sensitive and glucose tolerant than WT mice after HFD week 12.

CONCLUSION

TWEAK constrains "healthy" gAT expansion and promotes metabolic complications in severe obesity.

摘要

目的

研究肿瘤坏死因子样凋亡弱诱导剂(TWEAK)在病理性脂肪组织(AT)重塑和肥胖并发症中的作用。

方法

将野生型(WT)和 TWEAK 敲除(KO)小鼠分别用正常饮食(ND)或高脂肪饮食(HFD)喂养长达 17 周。使用已建立的诱导脂肪细胞凋亡的转基因小鼠模型(FAT-ATTAC)诱导脂肪细胞死亡。进行代谢、生化、组织学和流式细胞术分析。

结果

WT 小鼠的性腺(g)AT 在 HFD 第 4 周和脂肪细胞凋亡后 24 小时 TWEAK 和其受体成纤维细胞生长因子诱导分子 14(Fn14)上调。在 HFD 第 8 周前,KO 和 WT 小鼠的表型没有区别。然而,在第 17 周时,肥胖的 KO 小鼠的 gAT 脂肪细胞和 gAT 质量比 WT 小鼠大 30%左右,这与脂肪细胞死亡减少、胰岛素信号增强、Th2/M2 免疫偏向、胶原纤维变厚减少以及细胞外基质成分和调节剂的表达改变有关,这些改变与纤维化减少和脂肪细胞增大一致。与 WT 小鼠相比,KO 小鼠在 HFD 第 12 周后脂肪变性更少,胰岛素敏感性和葡萄糖耐量更高。

结论

TWEAK 限制了“健康”的 gAT 扩张,并促进了严重肥胖的代谢并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/32ff010be086/nihms568229f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/893aa2b46ed8/nihms568229f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/852bb2bb2187/nihms568229f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/42b1f8a6c1f9/nihms568229f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/45479a2bdf07/nihms568229f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/145fad610b74/nihms568229f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/fdb88fec34be/nihms568229f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/b321b39f3c5f/nihms568229f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/32ff010be086/nihms568229f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/893aa2b46ed8/nihms568229f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/852bb2bb2187/nihms568229f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/42b1f8a6c1f9/nihms568229f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/45479a2bdf07/nihms568229f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/145fad610b74/nihms568229f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/fdb88fec34be/nihms568229f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/b321b39f3c5f/nihms568229f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef0/4283503/32ff010be086/nihms568229f8.jpg

相似文献

1
Deletion of TNF-like weak inducer of apoptosis (TWEAK) protects mice from adipose and systemic impacts of severe obesity.删除肿瘤坏死因子样弱凋亡诱导因子(TWEAK)可保护小鼠免受严重肥胖的脂肪和全身影响。
Obesity (Silver Spring). 2014 Jun;22(6):1485-94. doi: 10.1002/oby.20726. Epub 2014 Mar 8.
2
Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia.肿瘤坏死样凋亡弱诱导因子作为人脂肪细胞中的促炎细胞因子:在严重肥胖中的上调是由炎症而不是缺氧介导的。
J Clin Endocrinol Metab. 2010 Jun;95(6):2983-92. doi: 10.1210/jc.2009-2481. Epub 2010 Apr 9.
3
Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.肿瘤坏死因子样凋亡弱诱导剂或Fn14缺乏可减少弹性蛋白酶灌注诱导的小鼠腹主动脉瘤。
J Am Heart Assoc. 2014 Aug 4;3(4):e000723. doi: 10.1161/JAHA.113.000723.
4
TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice.TWEAK/Fn14信号通路对于小鼠部分肝切除术后的肝脏再生是必需的。
PLoS One. 2014 Jan 9;9(1):e83987. doi: 10.1371/journal.pone.0083987. eCollection 2014.
5
The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.肿瘤坏死因子样凋亡弱诱导剂与其受体成纤维细胞生长因子诱导蛋白 14 之间的相互作用促进中性粒细胞向缺血性大脑的募集。
J Cereb Blood Flow Metab. 2010 Jun;30(6):1147-56. doi: 10.1038/jcbfm.2009.280. Epub 2010 Jan 13.
6
TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice.TWEAK/Fn14 通路促进小鼠辅助性 T 细胞 2 型慢性结肠炎伴纤维化。
Mucosal Immunol. 2013 Nov;6(6):1131-42. doi: 10.1038/mi.2013.10. Epub 2013 Mar 6.
7
The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.细胞因子肿瘤坏死因子样弱凋亡诱导因子及其受体成纤维细胞生长因子诱导 14 在中枢神经系统中具有神经保护作用。
J Neuroinflammation. 2012 Mar 6;9:45. doi: 10.1186/1742-2094-9-45.
8
Effects of TWEAK (TNF superfamily member 12) on differentiation, metabolism, and secretory function of human primary preadipocytes and adipocytes.TWEAK(肿瘤坏死因子超家族成员 12)对人原代前体脂肪细胞和脂肪细胞的分化、代谢和分泌功能的影响。
Endocrinology. 2009 Dec;150(12):5373-83. doi: 10.1210/en.2009-0488. Epub 2009 Nov 3.
9
TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.TWEAK/Fn14 通路是视网膜新生血管的一个新的介导者。
Invest Ophthalmol Vis Sci. 2014 Feb 10;55(2):801-13. doi: 10.1167/iovs.13-12812.
10
Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.肿瘤坏死因子样凋亡弱诱导物和成纤维细胞生长因子诱导 14 介导脑缺血诱导的多聚(ADP-核糖)聚合酶-1 激活和神经元死亡。
Neuroscience. 2010 Dec 29;171(4):1256-64. doi: 10.1016/j.neuroscience.2010.10.029. Epub 2010 Oct 16.

引用本文的文献

1
TWEAK/Fn14 hypomethylation and higher plasma TWEAK and TNF-α levels are related to sarcopenic obesity in community-dwelling elderly in Xinjiang.TWEAK/Fn14低甲基化以及血浆中TWEAK和TNF-α水平升高与新疆社区老年人肌少症性肥胖有关。
Medicine (Baltimore). 2025 Jul 4;104(27):e42937. doi: 10.1097/MD.0000000000042937.
2
Novel Hyperplastic Expansion of White Adipose Tissue Underlies the Metabolically Healthy Obese Phenotype of Male LFABP Null Mice.白色脂肪组织的新型增生性扩张是雄性肝脏型脂肪酸结合蛋白缺失小鼠代谢健康肥胖表型的基础。
Cells. 2025 May 22;14(11):760. doi: 10.3390/cells14110760.
3
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota.

本文引用的文献

1
Extended lifespan and reduced adiposity in mice lacking the FAT10 gene.FAT10 基因缺失的小鼠寿命延长且肥胖减少。
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5313-8. doi: 10.1073/pnas.1323426111. Epub 2014 Mar 24.
2
TWEAK: A New Player in Obesity and Diabetes.肿瘤坏死因子样弱凋亡诱导因子:肥胖和糖尿病领域的新角色。
Front Immunol. 2013 Dec 30;4:488. doi: 10.3389/fimmu.2013.00488.
3
Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.前沿:IL-25 诱导先天淋巴样细胞 2 型和 II 型 NKT 细胞,调节小鼠肥胖。
代谢综合征与银屑病:慢性炎症与肠道微生物群的关键作用。
Int J Mol Sci. 2024 Jul 25;25(15):8098. doi: 10.3390/ijms25158098.
4
Circulating sTweak is associated with visceral adiposity and severity in patients with obstructive sleep apnea syndrome.循环 sTweak 与阻塞性睡眠呼吸暂停综合征患者的内脏肥胖和严重程度相关。
Sci Rep. 2021 Nov 11;11(1):22058. doi: 10.1038/s41598-021-01553-3.
5
ColXV Aggravates Adipocyte Apoptosis by Facilitating Abnormal Extracellular Matrix Remodeling in Mice.ColXV 加剧脂肪细胞凋亡,促进小鼠细胞外基质异常重塑。
Int J Mol Sci. 2020 Jan 31;21(3):959. doi: 10.3390/ijms21030959.
6
A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease.从微环境到宏观环境的旅程:代谢性炎症和表观遗传变化在心脏肾脏疾病中的作用。
Clin Kidney J. 2019 Sep 18;12(6):861-870. doi: 10.1093/ckj/sfz106. eCollection 2019 Dec.
7
Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development.网膜素、内脏脂肪素、心肌营养素-1、肿瘤坏死因子样弱凋亡诱导因子及肾母细胞瘤过度表达基因/富半胱氨酸蛋白3在肥胖和糖尿病发生发展中的作用
Int J Mol Sci. 2017 Aug 15;18(8):1770. doi: 10.3390/ijms18081770.
8
TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice.TWEAK 阻断通过抑制糖尿病小鼠中 STAT1 信号通路来减少动脉粥样硬化病变的大小和进展。
Sci Rep. 2017 Apr 27;7:46679. doi: 10.1038/srep46679.
9
Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation.巨噬细胞溶酶体的胞吐作用导致凋亡脂肪细胞的消化和泡沫细胞形成。
J Lipid Res. 2016 Jun;57(6):980-92. doi: 10.1194/jlr.M064089. Epub 2016 Apr 4.
10
Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction.骨骼肌中TWEAK水平升高会促进内脏肥胖、胰岛素抵抗和代谢功能障碍。
FASEB J. 2015 Mar;29(3):988-1002. doi: 10.1096/fj.14-260703. Epub 2014 Dec 2.
J Immunol. 2013 Dec 1;191(11):5349-53. doi: 10.4049/jimmunol.1301176. Epub 2013 Oct 28.
4
The mechanical properties of human adipose tissues and their relationships to the structure and composition of the extracellular matrix.人体脂肪组织的机械性能及其与细胞外基质结构和组成的关系。
Am J Physiol Endocrinol Metab. 2013 Dec;305(12):E1427-35. doi: 10.1152/ajpendo.00111.2013. Epub 2013 Oct 8.
5
The TWEAK-Fn14 system as a potential drug target.TWEAK-Fn14系统作为一种潜在的药物靶点。
Br J Pharmacol. 2013 Oct;170(4):748-64. doi: 10.1111/bph.12337.
6
Fibrosis and adipose tissue dysfunction.纤维化与脂肪组织功能障碍。
Cell Metab. 2013 Oct 1;18(4):470-7. doi: 10.1016/j.cmet.2013.06.016. Epub 2013 Aug 15.
7
Innate immune activation in obesity.肥胖中的固有免疫激活。
Mol Aspects Med. 2013 Feb;34(1):12-29. doi: 10.1016/j.mam.2012.10.002. Epub 2012 Oct 13.
8
'Metabolically healthy obesity': origins and implications.代谢健康型肥胖:起源与意义。
Mol Aspects Med. 2013 Feb;34(1):59-70. doi: 10.1016/j.mam.2012.10.004. Epub 2012 Oct 13.
9
The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance.适应性免疫系统作为脂肪组织炎症和胰岛素抵抗的基本调节因子。
Immunol Cell Biol. 2012 Sep;90(8):755-62. doi: 10.1038/icb.2011.110. Epub 2012 Jan 10.
10
Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma.肥胖症中的脂肪生成和胰岛素敏感性受视黄醇相关孤儿受体γ的调节。
EMBO Mol Med. 2011 Nov;3(11):637-51. doi: 10.1002/emmm.201100172. Epub 2011 Aug 19.